AEM vs ASH

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

The Advanced Deterministic Scorecard reveals a deeply concerning financial profile with a Piotroski F-Score of just 2/9, indicating severe weakness in fundamental health. Despite a reasonable forward P/E of 13.53 and a 2.63% dividend yield, the company is plagued by a negative profit margin (-46.33%) and ROE (-34.45%), driven by a catastrophic earnings miss in Q3 2025. While the technical trend shows short-term recovery (+25.4% over 6M), long-term performance remains weak (-38.5% over 3Y), and analyst targets offer only marginal upside. Persistent earnings disappointment, lack of insider support, and deteriorating profitability undermine any value proposition.